Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet’s disease patients

References

• Ureten K, Ertenli I, Oztürk MA, Kiraz S, Onat AM, Tuncer M et al. Neutrophil CD64 expression in Behçet’s disease. J Rheumatol 2005;32:849–852.
   PubMed Web of Science ®Google Scholar
• Mishima K, Ichikawa Y, Shimizu H, Yoshida M, Arimori S. Cell surface antigens expressed on polymorphonuclear cells in the peripheral blood from patients with inflammatory rheumatic diseases: Two-color flow-cytometric analysis. Tokai J Exp Clin Med 1992;17:41–51.
   PubMedGoogle Scholar
• Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 2002;11:87–93.
   PubMed Web of Science ®Google Scholar
• Haznedaroglu E, Karaaslan Y, Büyükasik Y, Kosar A, Ozcebe O, Haznedaroglu C et al. Selectin adhesion molecules in Behçet’s disease. Ann Rheum Dis 2000;59:61–63.
   PubMed Web of Science ®Google Scholar
• Durmazlar SP, Ulkar GB, Eskioglu F, Tatlican S, Mert A, Akgul A. Significance of serum interleukin-8 levels in patients with Behcet’s disease: High levels may indicate vascular involvement. Int J Dermatol 2009;48:259–264.
   PubMed Web of Science ®Google Scholar
• Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I, Kocar IH. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet’s patients with venous thrombosis. Clin Exp Rheumatol 2005;23:S42–S48.
   PubMed Web of Science ®Google Scholar
• Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis ChC. Serum of patients with Behçet’s disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology (Basel) 2003;206:225–232.
   PubMed Web of Science ®Google Scholar
• Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991;77:2553–2555.
   PubMed Web of Science ®Google Scholar
• Assaad-Khalil SH, Abou-Seif M, Youssef I, Farahat N. L-selectin expression on leukocytes of patients with Behçet’s disease. Adv Exp Med Biol 2003;528:273–278.
   PubMed Web of Science ®Google Scholar
• de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH et al. Granulocyte colony-stimulating factor administration to healthy volunteers: Analysis of the immediate activating effects on circulating neutrophils. Blood 1994;84:3885–3894.
   PubMed Web of Science ®Google Scholar
• Tsutsui K, Hasegawa M, Takata M, Takehara K. Increased plasma granulocyte elastase levels in Behçet’s disease. J Rheumatol 1998;25:326–328.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341:1284–1291.
   PubMed Web of Science ®Google Scholar
• House SD, Lipowsky HH. Leukocyte-endothelium adhesion: Microhemodynamics in mesentery of the cat. Microvasc Res 1987;34:363–379.
   PubMed Web of Science ®Google Scholar
• Perry MA, Granger DN. Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991;87:1798–1804.
   PubMed Web of Science ®Google Scholar
• Sumagin R, Sarelius IH. TNF-alpha activation of arterioles and venules alters distribution and levels of ICAM-1 and affects leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 2006;291:H2116–H2125.
   PubMed Web of Science ®Google Scholar
• De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60–68.
   PubMed Web of Science ®Google Scholar
• Kalogeris TJ, Kevil CG, Laroux FS, Coe LL, Phifer TJ, Alexander JS. Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Physiol 1999;276:L9–L19.
   PubMedGoogle Scholar
• Duygulu F, Evereklioglu C, Calis M, Borlu M, Cekmen M, Ascioglu O. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet’s disease: A pilot study. Clin Rheumatol 2005;24:324–330.
   PubMed Web of Science ®Google Scholar
• Aslan M, Freeman BA. Oxidases and oxygenases in regulation of vascular nitric oxide signaling and inflammatory responses. Immunol Res 2002;26:107–118.
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet’s Disease: Criteria for diagnosis of Behçet’s disease. Lancet 1990;335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Aslan M, Yucel G, Bozcuk H, Savas B. The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy. Cancer Immunol Immunother 1998;47:176–181.
   PubMed Web of Science ®Google Scholar
• Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 2001;98:15215–15220.
   PubMed Web of Science ®Google Scholar
• Aslan M, Canatan D. Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp Hematol 2008;36:1535–1544.
   PubMed Web of Science ®Google Scholar
• Maloney CG, Kutchera WA, Albertine KH, McIntyre TM, Prescott SM, Zimmerman GA. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils. J Immunol 1998;160:1402–1410.
   PubMed Web of Science ®Google Scholar
• Pouliot M, Gilbert C, Borgeat P, Poubelle PE, Bourgoin S, Créminon C et al. Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. Faseb J 1998;12:1109–1123.
   PubMed Web of Science ®Google Scholar
• Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046–2050.
   PubMed Web of Science ®Google Scholar
• Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544–1549.
   PubMed Web of Science ®Google Scholar
• Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto-oxidative damage in Behçet’s disease–endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49:247–255.
   PubMed Web of Science ®Google Scholar
• Yazici C, Köse K, Calis M, DemIr M, Kirnap M, Ates F. Increased advanced oxidation protein products in Behçet’s disease: A new activity marker? Br J Dermatol 2004;151:105–111.
   PubMed Web of Science ®Google Scholar
• Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365–376.
   PubMed Web of Science ®Google Scholar
• Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002;296:2391–2394.
   PubMed Web of Science ®Google Scholar
• Baldus S, Eiserich JP, Mani A, Castro L, Figueroa M, Chumley P et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001;108:1759–1770.
   PubMed Web of Science ®Google Scholar
• Yildirim M, Baysal V, Inaloz HS, Doguc D. The significance of serum nitric oxide levels in Behçet’s disease and recurrent aphthous stomatitis. J Dermatol 2004;31:983–988.
   PubMed Web of Science ®Google Scholar
• Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoç M. Decreased nitric oxide production in patients with Behçet’s disease. Dermatology (Basel) 1999;198:33–36.
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature 1996;380:221–226.
   PubMed Web of Science ®Google Scholar
• Cedergren J, Follin P, Forslund T, Lindmark M, Sundqvist T, Skogh T. Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils. Apmis 2003;111:963–968.
   PubMed Web of Science ®Google Scholar
• Yan L, Vandivier RW, Suffredini AF, Danner RL. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J Immunol 1994;153:1825–1834.
   PubMed Web of Science ®Google Scholar
• Goker B, Goker H. Current therapy for Behçet’s disease. Am J Ther 2002;9:465–470.
   PubMedGoogle Scholar
• Gürer MA, Keskin N, Gülekon A, Karel L, Aksakal B, Baysal V. Arachidonic acid metabolites and colchicine in Behçet’s disease (BD). Prostaglandins Leukot Essent Fatty Acids 1991;43:257–259.
   PubMed Web of Science ®Google Scholar
• Brooks P, Emery P, Evans JF, Fenner H, Hawkey CJ, Patrono C et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) 1999;38:779–788.
   PubMed Web of Science ®Google Scholar